Both adipokines are clinically very relevant in prediabetes and diabetes, with the general perception that they exert contrary effects—leptin upregulates proinflammatory pathways which are associated with type 2 diabetes and cardiovascular disease, while adiponectin downregulates them [26]. Here, LEP is linked to type 2 diabetes mellitus.